These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22174554)

  • 21. Long-term outcomes of thalidomide in refractory Crohn's disease.
    Gerich ME; Yoon JL; Targan SR; Ippoliti AF; Vasiliauskas EA
    Aliment Pharmacol Ther; 2015 Mar; 41(5):429-37. PubMed ID: 25511905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-TNF therapy in treatment of luminal Crohn's disease].
    Marko B; Prka L
    Acta Med Croatica; 2013 Apr; 67(2):179-89. PubMed ID: 24471301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.
    Vasudevan A; Raghunath A; Anthony S; Scanlon C; Sparrow MP; Gibson PR; van Langenberg DR
    Dig Dis Sci; 2019 Jun; 64(6):1622-1631. PubMed ID: 30560332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
    Absah I; Faubion WA
    Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Infliximab in Crohn's Disease Patients with Prior Primary-Nonresponse to Tumor Necrosis Factor Antagonists.
    Clark-Snustad KD; Singla A; Lee SD
    Dig Dis Sci; 2019 Jul; 64(7):1952-1958. PubMed ID: 30815825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there a benefit from the concomitant use of immunosupression with anti-TNF in Crohn's disease; heads or tails?
    Lakatos PL
    Rev Recent Clin Trials; 2009 Sep; 4(3):152-8. PubMed ID: 20028325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of long-term treatment with thalidomide in children and young adults with Crohn disease: preliminary results.
    Facchini S; Candusso M; Martelossi S; Liubich M; Panfili E; Ventura A
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):178-81. PubMed ID: 11321389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease.
    Mansfield JC; Parkes M; Hawthorne AB; Forbes A; Probert CS; Perowne RC; Cooper A; Zeldis JB; Manning DC; Hawkey CJ
    Aliment Pharmacol Ther; 2007 Aug; 26(3):421-30. PubMed ID: 17635377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: long-term results.
    Lazzerini M; Martelossi S; Marchetti F; Scabar A; Bradaschia F; Ronfani L; Ventura A
    Aliment Pharmacol Ther; 2007 Feb; 25(4):419-27. PubMed ID: 17269997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary].
    Kiss LS; Szamosi T; Molnár T; Miheller P; Lakatos L; Vincze A; Palatka K; Bartha Z; Gasztonyi B; Salamon A; Horváth G; Tóth GT; Farkas K; Banai J; Tulassay Z; Nagy F; Szenes M; Veres G; Lovász BD; Végh Z; Golovics PA; Szathmári M; Papp M; Lakatos PL
    Orv Hetil; 2011 Sep; 152(36):1433-42. PubMed ID: 21865144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
    Chaparro M; Barreiro-de Acosta M; Echarri A; Almendros R; Barrio J; Llao J; Gomollón F; Vera M; Cabriada JL; Guardiola J; Guerra I; Beltrán B; Roncero O; Busquets D; Taxonera C; Calvet X; Ferreiro-Iglesias R; Ollero Pena V; Bernardo D; Donday MG; Garre A; Godino A; Díaz A; Gisbert JP
    Dig Dis Sci; 2019 Mar; 64(3):846-854. PubMed ID: 30426297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.
    Krygier DS; Ko HH; Bressler B
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):407-15. PubMed ID: 19673627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-alpha, in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy? The Infliximab User Group.
    Mortimore M; Gibson PR; Selby WS; Radford-Smith GL; Florin TH;
    Intern Med J; 2001 Apr; 31(3):146-50. PubMed ID: 11478343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The state of the art on treatment of Crohn's disease.
    Shi HY; Ng SC
    J Gastroenterol; 2018 Sep; 53(9):989-998. PubMed ID: 29980848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early studies on the safety and efficacy of thalidomide for symptomatic inflammatory bowel disease.
    Bariol C; Meagher AP; Vickers CR; Byrnes DJ; Edwards PD; Hing M; Wettstein AR; Field A
    J Gastroenterol Hepatol; 2002 Feb; 17(2):135-9. PubMed ID: 11966942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease.
    Akobeng AK; Zachos M
    Cochrane Database Syst Rev; 2004; 2003(1):CD003574. PubMed ID: 14974022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of pediatric refractory Crohn's disease with thalidomide.
    Zheng CF; Xu JH; Huang Y; Leung YK
    World J Gastroenterol; 2011 Mar; 17(10):1286-91. PubMed ID: 21455327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide-induced sinus bradycardia in Crohn's disease: case report and literature review.
    Liu M; Lin X; Wang L; He Y; Chen M; Mao R
    J Int Med Res; 2019 May; 47(5):2228-2233. PubMed ID: 30832535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
    Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
    Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-TNF agents in Crohn's disease.
    Van Assche G; Rutgeerts P
    Expert Opin Investig Drugs; 2000 Jan; 9(1):103-11. PubMed ID: 11060664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.